インターベンショナル腫瘍学市場：製品タイプ、がんタイプ、技術、エンドユーザー別-2025-2030年の世界予測

インターベンショナルオンコロジー市場の2024年の市場規模は25億5,000万米ドルで、2025年には27億3,000万米ドル、CAGR 7.39%で成長し、2030年には39億2,000万米ドルに達すると予測されています。

インターベンショナルオンコロジーの総合イントロダクション

インターベンショナルオンコロジーは、最先端の技術革新とがん生物学への深い理解が融合した、ダイナミックかつ急速に進歩する分野です。今日の複雑なヘルスケア環境において、この専門分野は悪性腫瘍の管理・治療における重要な要素として台頭してきています。低侵襲技術の導入は、治療のパラダイムを再定義しただけでなく、従来の外科手術に代わる、より安全で効果的な選択肢を患者に提供しています。腫瘍学の発展分野として、インターベンショナルオンコロジーは、精巧な画像診断、オーダーメイドの機器、マルチモダリティのアプローチを活用し、精度と正確性を高めることで、患者の転帰を改善しています。

本レポートは、この分野の現状と将来の可能性について包括的な見解を示しています。主要な技術動向、市場促進要因、機器開発におけるイノベーションを分析しています。また、さまざまながん種における臨床応用や、その結果としての治療戦略の変革についても考察しています。実用的な洞察に焦点を当てた本サマリーは、戦略的ガイドと知識の保管庫の両方の役割を果たし、実務者、意思決定者、業界リーダー同様に貴重な視点を提供します。

本レポートは、急速に変化するヘルスケア情勢における適応性の重要性を強調し、市場セグメント、地域開発、腫瘍学のこの専門領域を形成する競合力学の詳細な検証のための舞台を設定します。そうすることで、インターベンショナルオンコロジーにおける次のブレークスルーの波を推進する上で、調査と協力が不可欠な役割を果たすことを強調しています。

インターベンショナルオンコロジーの情勢における変革的変化

近年、インターベンショナル・オンコロジーの領域を再形成するような変革が起きています。技術の進歩は、がんの臨床管理を塗り替えるような新しいツールやアプローチをもたらしました。この進化は、精度の向上、安全性プロファイルの改善、より個別化された治療プロトコルの必要性によって大きく後押しされています。

革新的な画像診断技術は、小型化され高度に専門化された装置の進化と相まって、臨床医が複雑な腫瘍の解剖学的構造を驚くべき精度でナビゲートすることを可能にしました。これらの開発により、治療時間と入院期間が大幅に短縮されるとともに、より侵襲的な処置に伴う副作用も最小限に抑えられています。人工知能と予測分析の統合はさらに臨床的意思決定をサポートし、治療がタイムリーであるだけでなく、個々の患者のプロファイルに合わせたものとなることを保証します。

さらに、工学、放射線学、腫瘍学にまたがる学際的専門知識の融合が、こうした変革的シフトのバックボーンを形成しています。この全体的な統合は、治療プロセス全体を強化し、患者ケアを合理化します。市場の情勢が進化を続ける中、従来のパラダイムに課題する新たな治療法や手技の革新が登場しています。こうした変化から得られる勢いは、利害関係者による継続的な適応の必要性を強調し、この分野の力強い成長と革新への道を開くものです。

主なセグメンテーションの洞察と市場力学

インターベンショナルオンコロジーの市場力学を理解する上で重要なのは、主要なセグメンテーションパラメータの包括的分析です。製品次元の研究から、アブレーション、塞栓術、支持器具を含むスペクトルが明らかになりました。これらのカテゴリーはそれぞれ、アブレーションデバイスでは冷凍アブレーションデバイスや高密度焦点式超音波、塞栓デバイスでは薬剤溶出ビーズやマイクロスフェア、支持デバイスではガイドワイヤーやイントロダクションキットといった特殊なコンポーネントに分類されます。このように詳細に分類することで、利害関係者はニッチな機会を特定し、さまざまな臨床介入の特定のニーズに対応することができます。

がんの種類に基づくセグメンテーションは、大腸がん、腎臓がん、肝臓がん、肺がんに市場を分類することで、この分析をさらに精緻化します。これらの分類は、多様な臨床応用と、がんによって異なる罹患率を強調するものであり、ひいては技術の採用と研究の優先順位付けに影響を与えます。

さらに、ブラキセラピー、画像誘導放射線治療、マイクロ波アブレーション、高周波アブレーションを包含する技術区分は、革新的な治療様式を急速に統合している分野の絵を描いています。このレイヤーアプローチは、手技の複雑さと新たな競合優位性についての詳細なビューを提供します。

最後に、エンドユーザー別のセグメンテーションでは、外来手術センター、がん研究機関、病院などの主要な臨床環境に焦点を当てています。これらのセグメントを分析することで、患者管理を強化するためのインフラ需要やテクノロジーの進化する役割について、実用的な洞察が得られます。これらのセグメンテーションを総合すると、市場の微妙な理解が可能となり、成長動向や戦略的投資が必要な分野が浮き彫りになります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的にがんの罹患率が増加
    • 患者と医療提供者の間で治療オプションとしてのインターベンショナルオンコロジーの認知度と受容度が高まっている
    • 世界中でヘルスケア費と投資が増加
  • 抑制要因
    • インターベンショナルオンコロジー手続きに関連する高コスト
  • 機会
    • インターベンショナルオンコロジーにおけるワークフローと診断の最適化における人工知能の統合
    • 低侵襲がん治療のための凍結アブレーション技術の進歩
  • 課題
    • 新興の臨床的有効性と安全性に関する懸念に対処するインターベンショナルオンコロジー
• 市場セグメンテーション分析
  • 製品：低侵襲性と腫瘍破壊の有効性により、アブレーションデバイスの重要性が高まっています
  • エンドユーザー：外来手術センターにおけるインターベンショナルオンコロジーの採用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 インターベンショナルオンコロジー市場：製品別

• アブレーションデバイス
  • 凍結アブレーション装置
  • 高強度焦点式超音波
• 塞栓デバイス
  • 薬剤溶出ビーズ
  • マイクロスフェア
• 補助器具
  • ガイドワイヤー キット

第7章 インターベンショナルオンコロジー市場がんの種類別

• 大腸がん
• 腎臓がん
• 肝臓がん
• 肺がん

第8章 インターベンショナルオンコロジー市場：技術別

• 近接放射線療法
• 画像誘導放射線治療
• マイクロ波アブレーション
• 高周波アブレーション

第9章 インターベンショナルオンコロジー市場：エンドユーザー別

• 外来手術センター
• がん調査機関
• 病院

第10章 南北アメリカのインターベンショナルオンコロジー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のインターベンショナルオンコロジー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのインターベンショナルオンコロジー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Accuray Incorporated
• Alpinion Medical Systems Co., Ltd.
• AngioDynamics, Inc.
• Atricure, Inc.
• BALT Group
• Bayer AG
• Boston Scientific Corporation
• Cook Group Incorporated
• Eckert & Ziegler BEBIG AG
• Fujifilm Holdings Corporation
• GE Healthcare
• Hologic, Inc.
• IceCure Medical Ltd.
• Integer Holding Corporation
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Medtronic PLC
• Merit Medical Systems
• Profound Medical Corp.
• Siemens Healthineers
• Sirtex Medical Limited
• Sonablate Corp
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET MULTI-CURRENCY
• FIGURE 2. INTERVENTIONAL ONCOLOGY MARKET MULTI-LANGUAGE
• FIGURE 3. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
• FIGURE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTERVENTIONAL ONCOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CRYOABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY INTRODUCTION KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 58. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 59. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 60. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 95. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 96. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 98. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 104. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 105. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 222. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 224. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 225. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 226. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 248. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 249. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 251. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 252. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 253. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 254. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 255. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 257. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 258. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 259. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 260. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 261. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 325. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 326. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

The Interventional Oncology Market was valued at USD 2.55 billion in 2024 and is projected to grow to USD 2.73 billion in 2025, with a CAGR of 7.39%, reaching USD 3.92 billion by 2030.

Comprehensive Introduction to Interventional Oncology

Interventional oncology represents a dynamic and rapidly advancing field that combines cutting-edge technological innovations with a deep understanding of cancer biology. In today's complex healthcare environment, this specialty is emerging as a critical component in the management and treatment of malignant tumors. The introduction of minimally invasive techniques has not only redefined treatment paradigms but has also provided patients with safer, more effective alternatives to traditional surgical procedures. As an evolving sphere within oncology, interventional oncology leverages sophisticated imaging, tailored devices, and multi-modality approaches that enhance precision and accuracy, thereby improving patient outcomes.

This report offers an overarching view of the current state and future possibilities within the field. It encompasses an analysis of leading technological trends, key market drivers, and innovations in device development. The discussion extends to the clinical applications across various cancer types and the resultant transformations in therapeutic strategies. With a focus on actionable insights, this summary serves as both a strategic guide and a knowledge repository, offering valuable perspectives for practitioners, decision-makers, and industry leaders alike.

Emphasizing the importance of adaptability in a rapidly shifting healthcare landscape, the report sets the stage for a detailed examination of market segments, regional developments, and the competitive dynamics shaping this specialized area of oncology. In doing so, it highlights the integral role of research and collaboration in driving forward the next wave of breakthroughs in interventional oncology.

Transformative Shifts in the Landscape of Interventional Oncology

Recent years have witnessed transformative changes that are reshaping the realm of interventional oncology. Technological advancements have ushered in novel tools and approaches that are rewriting the clinical management of cancer. This evolution is largely driven by the need for enhanced precision, improved safety profiles, and more personalized treatment protocols.

Innovative imaging techniques, coupled with the evolution of miniaturized and highly specialized devices, have enabled clinicians to navigate complex tumor anatomies with remarkable accuracy. These developments significantly reduce treatment time and hospital stays, while also minimizing adverse effects associated with more invasive procedures. The integration of artificial intelligence and predictive analytics further supports clinical decision-making, ensuring that treatments are not only timely but also tailored to individual patient profiles.

Furthermore, the convergence of interdisciplinary expertise-spanning engineering, radiology, and oncology-forms the backbone of these transformative shifts. This holistic integration enhances the overall therapeutic process and streamlines patient care. As the landscape continues to evolve, the market is witnessing the emergence of novel therapeutic modalities and procedural innovations that challenge conventional paradigms. The momentum garnered from these changes emphasizes the need for continuous adaptation by stakeholders and paves the way for robust growth and innovation in the sector.

Key Segmentation Insights and Market Dynamics

Critical to understanding the market dynamics in interventional oncology is a comprehensive analysis of key segmentation parameters. The study of the product dimension reveals a spectrum that includes ablation, embolization, and supportive devices. Each of these categories is dissected further into specialized components such as cryoablation devices and high-intensity focused ultrasound within ablation devices; drug-eluting beads and microspheres within embolization devices; and guidewires and introduction kits classified under supportive devices. Such detailed categorization allows stakeholders to identify niche opportunities and address the specific needs of various clinical interventions.

Segmentation based on cancer type further refines this analysis by categorizing the market according to colorectal, kidney, liver, and lung cancers. These classifications underscore the diverse clinical applications and the variable incidence rates across different cancers, which in turn influence technology adoption and research prioritization.

Moreover, technological segmentation that encompasses brachytherapy, image-guided radiotherapy, microwave ablation, and radiofrequency ablation paints a picture of a field that is rapidly integrating innovative treatment modalities. This layered approach provides an in-depth view into the procedural intricacies and emerging competitive advantages.

Lastly, segmentation by end-user focuses on key clinical settings such as ambulatory surgical centers, cancer research institutes, and hospitals. Analyzing these segments offers actionable insights into the infrastructural demands and the evolving role of technology in enhancing patient management. Collectively, these segmentation insights provide a nuanced understanding of the market, highlighting growth trends and areas that require strategic investment.

Based on Product, market is studied across Ablation Devices, Embolization Devices, and Supportive Devices. The Ablation Devices is further studied across Cryoablation Devices and High-Intensity Focused Ultrasound. The Embolization Devices is further studied across Drug-Eluting Beads and Microspheres. The Supportive Devices is further studied across Guidewires and Introduction Kits.

Based on Cancer Type, market is studied across Colorectal Cancer, Kidney Cancer, Liver Cancer, and Lung Cancer.

Based on Technology, market is studied across Brachytherapy, Image-Guided Radiotherapy, Microwave Ablation, and Radiofrequency Ablation.

Based on End-User, market is studied across Ambulatory Surgical Centers, Cancer Research Institutes, and Hospitals.

Essential Regional Insights Shaping the Global Market

A robust appraisal of regional trends reveals significant variations and emerging opportunities on a global scale. In the Americas, advanced healthcare infrastructure combined with rapid adoption of technological innovations serves as a fertile ground for interventional oncology applications. The region's emphasis on integrating state-of-the-art diagnostic modalities and treatment techniques fuels ongoing research and development, thereby propelling market growth.

Turning to Europe, the Middle East, and Africa, a diverse spectrum of healthcare systems fosters an environment that is both challenging and rich with potential. The region is characterized by robust government initiatives and a heightened focus on precision medicine, which paves the way for the incorporation of advanced treatment devices and methodologies. Collaborative efforts between public and private sectors in this region are fostering technological diffusion and clinical excellence.

In Asia-Pacific, the combination of a large patient pool and expanding healthcare budgets has notably accelerated the market uptake of interventional oncology innovations. The region is witnessing a surge in infrastructural investments, which is coupled with a growing emphasis on early cancer detection and minimally invasive treatments. These regional insights illustrate how marketplace dynamics can vary dramatically, yet each region contributes uniquely to the overall advancement of interventional oncology practices across the globe.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

In-Depth Analysis of Leading Companies and Competitive Landscape

The competitive dynamics within the interventional oncology market are defined by the strategic initiatives and technological innovations of leading companies. Esteemed organizations such as Abbott Laboratories, Accuray Incorporated, Alpinion Medical Systems Co., Ltd., AngioDynamics, Inc., Atricure, Inc., BALT Group, Bayer AG, Boston Scientific Corporation, Cook Group Incorporated, Eckert & Ziegler BEBIG AG, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IceCure Medical Ltd., Integer Holding Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Profound Medical Corp., Siemens Healthineers, Sirtex Medical Limited, Sonablate Corp, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation have played pivotal roles in shaping the market landscape.

These companies invest significantly in research and development, ensuring that their product offerings are at the forefront of innovation. Their portfolios not only encompass a range of sophisticated devices but also include innovative technical solutions that drive clinical efficiency and improved patient outcomes. Through strategic collaborations and mergers, the competitive arena continues to evolve, reflecting a trend towards greater consolidation in the industry.

Analyzing these companies offers several insights, including their market penetration strategies, focus on emerging technologies, and dedication to clinical validation. In addition, their extensive global networks allow them to effectively respond to regional needs and regulatory frameworks. As a result, their collective efforts are not only pushing technological boundaries but are also setting new benchmarks in patient care and clinical excellence.

The report delves into recent significant developments in the Interventional Oncology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuray Incorporated, Alpinion Medical Systems Co., Ltd., AngioDynamics, Inc., Atricure, Inc., BALT Group, Bayer AG, Boston Scientific Corporation, Cook Group Incorporated, Eckert & Ziegler BEBIG AG, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IceCure Medical Ltd., Integer Holding Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Profound Medical Corp., Siemens Healthineers, Sirtex Medical Limited, Sonablate Corp, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to adopt a multi-faceted strategy that addresses both the immediate and long-term challenges faced by the interventional oncology sector. A significant recommendation is to continue investing in research and digital transformation. Embracing innovations such as artificial intelligence, machine learning, and predictive analytics will enable a more precise alignment of treatment strategies with patient-specific needs.

Moreover, firms should focus on strengthening cross-disciplinary collaborations that integrate clinical expertise with technological advancements. By leveraging synergies between engineering, radiology, and oncology, practices can enhance procedural accuracy and broaden the scope of minimally invasive treatments. Strategic partnerships with research institutions and healthcare providers can also generate a robust pipeline of innovative solutions.

Operational excellence is another critical area; streamlining supply chains, optimizing production cycles, and ensuring regulatory compliance across diverse markets will be crucial. Leaders should also pay keen attention to regional market demands and patient demographics to tailor solutions that are both cost-effective and clinically impactful. Investing in workforce development and continuous training will further enable organizations to sustain competitive advantages.

Ultimately, these actionable steps form the foundation of a comprehensive strategy that not only optimizes current operations but also secures long-term market leadership in an increasingly competitive landscape.

Concise Conclusion and Strategic Insights

In conclusion, interventional oncology is advancing at a remarkable pace, driven by technological innovations, strategic market segmentation, and regional investments that collectively point to sustained industry growth. This evolving landscape presents significant opportunities for enhanced patient care, as well as challenges that require dynamic strategic responses.

Focused analysis across diverse segments, regions, and competitive benchmarks highlights the necessity for integrated approaches that combine clinical expertise with advanced technology. The insights gleaned from this comprehensive overview elucidate the key trends and strategic imperatives that will continue to shape the future of interventional oncology.

Stakeholders are thus well-positioned to capitalize on these emerging opportunities by aligning their strategies with the evolving market dynamics, thereby ensuring long-term success and resilience in a rapidly transforming field.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of cancer globally
    • 5.1.1.2. Rising awareness and acceptance of interventional oncology as a treatment option among patients and providers
    • 5.1.1.3. Increasing healthcare expenditure and investments in interventional oncology worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with interventional oncology procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of artificial intelligence in optimizing workflow and diagnosis in interventional oncology
    • 5.1.3.2. Advancements in cryoablation technology for minimally invasive cancer treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Addressing concerns about the clinical efficacy and safety of emerging interventional oncology
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising significance of ablation devices owing to their minimally invasive nature and effectiveness in tumour destruction
  • 5.2.2. End-User: Expanding adoption of interventional oncology among ambulatory surgical centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Interventional Oncology Market, by Product

• 6.1. Introduction
• 6.2. Ablation Devices
  • 6.2.1. Cryoablation Devices
  • 6.2.2. High-Intensity Focused Ultrasound
• 6.3. Embolization Devices
  • 6.3.1. Drug-Eluting Beads
  • 6.3.2. Microspheres
• 6.4. Supportive Devices
  • 6.4.1. Guidewires
  • 6.4.2. Introduction Kits

7. Interventional Oncology Market, by Cancer Type

• 7.1. Introduction
• 7.2. Colorectal Cancer
• 7.3. Kidney Cancer
• 7.4. Liver Cancer
• 7.5. Lung Cancer

8. Interventional Oncology Market, by Technology

• 8.1. Introduction
• 8.2. Brachytherapy
• 8.3. Image-Guided Radiotherapy
• 8.4. Microwave Ablation
• 8.5. Radiofrequency Ablation

9. Interventional Oncology Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Cancer Research Institutes
• 9.4. Hospitals

10. Americas Interventional Oncology Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Interventional Oncology Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Interventional Oncology Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Delcath Systems secures USD 16.3 million through warrant exercises to advance liver cancer treatment strategies
  • 13.3.2. Boston Scientific expands interventional oncology offerings with acquisition of Intera Oncology Inc to enhance liver cancer treatments
  • 13.3.3. Varian secures FDA clearance for IntelliBlate microwave ablation ecosystem
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Accuray Incorporated
• 3. Alpinion Medical Systems Co., Ltd.
• 4. AngioDynamics, Inc.
• 5. Atricure, Inc.
• 6. BALT Group
• 7. Bayer AG
• 8. Boston Scientific Corporation
• 9. Cook Group Incorporated
• 10. Eckert & Ziegler BEBIG AG
• 11. Fujifilm Holdings Corporation
• 12. GE Healthcare
• 13. Hologic, Inc.
• 14. IceCure Medical Ltd.
• 15. Integer Holding Corporation
• 16. Johnson & Johnson Services, Inc.
• 17. Koninklijke Philips N.V.
• 18. Medtronic PLC
• 19. Merit Medical Systems
• 20. Profound Medical Corp.
• 21. Siemens Healthineers
• 22. Sirtex Medical Limited
• 23. Sonablate Corp
• 24. Stryker Corporation
• 25. Teleflex Incorporated
• 26. Terumo Corporation